We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

124 hedge funds and large institutions have $57.3M invested in Sanofi Contingent Value Rights in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more capital invested

Capital invested by funds: $34.8M → $57.3M (+$22.5M)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1% less funds holding

Funds holding: 125 → 124 (-1)

59% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 27

Holders
124
Holders Change
-1
Holders Change %
-0.8%
% of All Funds
3.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
27
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
+$3.46M
2
Allianz Asset Management
Allianz Asset Management
Germany
+$1.02M
3
CPM
Chesapeake Partners Management
Maryland
+$1.01M
4
GCM
Gruss Capital Management
New York
+$447K
5
CCA
Catalyst Capital Advisors
New York
+$75.8K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$1.65M
2
Millennium Management
Millennium Management
New York
-$632K
3
SAM
Serengeti Asset Management
New York
-$543K
4
SAM
Silverback Asset Management
North Carolina
-$318K
5
OAM
Oxford Asset Management
United Kingdom
-$306K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Whitebox Advisors
Minnesota
$11.9M +$3.46M +7,144,724 +43%
FTCM
2
Fir Tree Capital Management
New York
$9.55M – – –
MCM
3
Mason Capital Management
New York
$7.53M – – –
GCM
4
Gruss Capital Management
New York
$4.21M +$447K +925,000 +12%
CPM
5
Chesapeake Partners Management
Maryland
$3.93M +$1.01M +2,096,022 +36%
Allianz Asset Management
6
Allianz Asset Management
Germany
$2.98M +$1.02M +2,110,867 +55%
MFP
7
Michael F. Price
$2.64M – – –
COPPSERS
8
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.59M – – –
CL
9
CSS LLC
Illinois
$1.38M -$6.04K -12,500 -0.5%
NM
10
Newtyn Management
New York
$1M – – –
SM
11
Scoggin Management
New York
$1M – – –
OAM
12
Oxford Asset Management
United Kingdom
$904K -$306K -632,029 -26%
Citigroup
13
Citigroup
New York
$776K – – –
Millennium Management
14
Millennium Management
New York
$769K -$632K -1,306,914 -46%
Brown Advisory
15
Brown Advisory
Maryland
$712K – – –
UOC
16
UBS O'Connor
Illinois
$602K – – –
GF
17
Gabelli Funds
New York
$550K -$43.5K -90,000 -8%
PC
18
Pomelo Capital
New York
$525K – – –
BPGAM
19
BTG Pactual Global Asset Management
Bermuda
$400K – – –
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$307K – – –
GI
21
GAMCO Investors
Connecticut
$280K -$34.3K -71,000 -11%
BMO
22
Beck Mack & Oliver
New York
$266K -$5.85K -12,100 -2%
ACM
23
Akanthos Capital Management
California
$250K – – –
Bank of America
24
Bank of America
North Carolina
$239K -$931 -1,926 -0.4%
TL
25
TowerView LLC
New York
$200K -$24.2K -50,000 -11%
1
2 3 4 5

GCVRZ Hedge Fund Activity: Q2 2014 in Review

124 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2014, worth a combined $57.3M — up 65% from $34.8M a quarter earlier.

Fund positioning in GCVRZ was balanced in Q2 2014: 7 funds opened new positions, 7 closed out, 11 added to existing stakes and 27 trimmed.

The largest buyer was Whitebox Advisors, adding an estimated $3.46M. The largest seller was Park West Asset Management, exiting entirely with an estimated $1.65M sold.

  • 124 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2014, down from 125 in Q1 2014.
  • Funds reported $57.3M of Sanofi Contingent Value Rights stock for Q2 2014, up 65% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q2 2014 and 7 closed out, a net change of 0 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2014 was Whitebox Advisors, an estimated $3.46M added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2014 was Park West Asset Management, an estimated $1.65M sold.

Based on aggregated 13F filings for Q2 2014.